Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00962390 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
A Phase 2 study, sponsored by Ausio Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 116
- Enrollment target
NCT00962390: Completed Phase 2 study, sponsored by Ausio Pharmaceuticals.
NCT00962390 is a Phase 2 study that has completed, run by Ausio Pharmaceuticals. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00962390, a Phase 2 study, has completed, sponsored by Ausio Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 116 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of S-equol in men with benign prostatic hyperplasia.
Interventions
- DRUG Placebo
- DRUG S-equol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2009-06 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00962390
The ClinicalTrials.gov registry entry for NCT00962390 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ausio Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00962390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00962390 about?
NCT00962390 is a clinical study titled "Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia". The purpose of this study is to assess the safety and effectiveness of S-equol in men with benign prostatic hyperplasia.
What is the current status of trial NCT00962390?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2009-06. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00962390?
The interventions under investigation include: Placebo (DRUG), S-equol (DRUG).
Who is sponsoring clinical trial NCT00962390?
This trial is sponsored by Ausio Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.